PURE BIOSCIENCE, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q2 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pure Bioscience, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q2 2011 to Q2 2024.
  • Pure Bioscience, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending July 31, 2024 was $29.3M, a 3.33% decline year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $29.3M -$1.01M -3.33% Jul 31, 2024 10-K 2024-10-29
Q2 2023 $30.3M +$820K +2.78% Jul 31, 2023 10-K 2024-10-29
Q2 2022 $29.5M +$670K +2.32% Jul 31, 2022 10-K 2023-10-30
Q2 2021 $28.8M +$470K +1.66% Jul 31, 2021 10-K 2022-10-28
Q2 2020 $28.4M -$470K -1.63% Jul 31, 2020 10-K 2021-10-28
Q2 2019 $28.8M +$210K +0.73% Jul 31, 2019 10-K 2020-10-08
Q2 2018 $28.6M -$5.45M -16% Jul 31, 2018 10-K 2019-10-30
Q2 2017 $34.1M +$67.4M Jul 31, 2017 10-K 2018-10-25
Q2 2016 -$33.3M -$64.1M -208% Jul 31, 2016 10-K 2017-10-26
Q2 2015 $30.8M +$3.08M +11.1% Jul 31, 2015 10-K 2016-10-27
Q2 2014 $27.8M +$3.12M +12.7% Jul 31, 2014 10-K 2015-10-28
Q2 2013 $24.6M +$2.09M +9.26% Jul 31, 2013 10-K 2014-10-28
Q2 2012 $22.6M +$2.66M +13.4% Jul 31, 2012 10-K 2013-10-24
Q2 2011 $19.9M Jul 31, 2011 10-K 2012-10-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.